James Stone

13.7k total citations · 5 hit papers
164 papers, 8.6k citations indexed

About

James Stone is a scholar working on Cognitive Neuroscience, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, James Stone has authored 164 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cognitive Neuroscience, 57 papers in Cellular and Molecular Neuroscience and 46 papers in Psychiatry and Mental health. Recurrent topics in James Stone's work include Functional Brain Connectivity Studies (50 papers), Neuroscience and Neuropharmacology Research (47 papers) and Schizophrenia research and treatment (39 papers). James Stone is often cited by papers focused on Functional Brain Connectivity Studies (50 papers), Neuroscience and Neuropharmacology Research (47 papers) and Schizophrenia research and treatment (39 papers). James Stone collaborates with scholars based in United Kingdom, United States and Netherlands. James Stone's co-authors include Oliver Howes, Philip McGuire, Allan H. Young, Robert A. McCutcheon, Paul D. Morrison, Lyn S. Pilowsky, Anthony J. Cleare, Alice Egerton, Viktoriya L. Nikolova and Luke A. Jelen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

James Stone

158 papers receiving 8.4k citations

Hit Papers

Neural correlates of the psychedelic state as determined ... 2009 2026 2014 2020 2012 2009 2015 2021 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
    2012 737 citations James Stone, Laurence Reed et al. profile →
  2. Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
    2009 541 citations Paul D. Morrison, Stefan Borgwardt et al. Neuropsychopharmacology profile →
  3. Glutamate and dopamine in schizophrenia: An update for the 21 st century
    2015 521 citations Oliver Howes, Robert A. McCutcheon et al. Journal of Psychopharmacology profile →
  4. Perturbations in Gut Microbiota Composition in Psychiatric Disorders
    2021 470 citations Viktoriya L. Nikolova, Anthony J. Cleare et al. JAMA Psychiatry profile →
  5. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
    2012 361 citations Amir Englund, Paul D. Morrison et al. Journal of Psychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Stone United Kingdom 46 2.8k 2.1k 2.1k 1.9k 1.7k 164 8.6k
Brian Pittman United States 58 2.3k 0.8× 1.8k 0.9× 2.2k 1.0× 1.8k 0.9× 1.0k 0.6× 264 9.5k
Jeffrey H. Meyer Canada 50 3.5k 1.2× 1.5k 0.7× 1.8k 0.9× 2.1k 1.1× 2.4k 1.4× 153 9.9k
Jarmo Hietala Finland 55 4.4k 1.6× 2.8k 1.3× 2.6k 1.3× 1.3k 0.7× 562 0.3× 239 10.1k
David Copolov Australia 51 2.3k 0.8× 3.8k 1.8× 1.9k 0.9× 852 0.5× 1.5k 0.9× 242 9.3k
William M. McDonald United States 52 1.7k 0.6× 3.2k 1.5× 3.3k 1.6× 2.0k 1.0× 1.2k 0.7× 161 11.7k
Nakao Iwata Japan 52 3.0k 1.1× 3.0k 1.4× 1.5k 0.7× 1.5k 0.8× 1.3k 0.8× 482 11.4k
Gregor Hasler Switzerland 44 2.1k 0.8× 1.4k 0.7× 2.4k 1.1× 1.1k 0.6× 1.5k 0.9× 148 8.9k
Shigenobu Kanba Japan 64 2.0k 0.7× 3.4k 1.6× 2.6k 1.2× 932 0.5× 2.4k 1.4× 324 14.1k
William G. Honer Canada 59 3.1k 1.1× 5.1k 2.4× 2.4k 1.2× 979 0.5× 1.0k 0.6× 406 14.0k
John Rotrosen United States 53 2.5k 0.9× 3.7k 1.7× 3.0k 1.4× 1.0k 0.5× 469 0.3× 282 10.4k

Countries citing papers authored by James Stone

Since Specialization
Citations

This map shows the geographic impact of James Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Stone more than expected).

Fields of papers citing papers by James Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Stone. The network helps show where James Stone may publish in the future.

Co-authorship network of co-authors of James Stone

This figure shows the co-authorship network connecting the top 25 collaborators of James Stone. A scholar is included among the top collaborators of James Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Stone. James Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nikolova, Viktoriya L., Anthony J. Cleare, Allan H. Young, & James Stone. (2023). Acceptability, Tolerability, and Estimates of Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression. JAMA Psychiatry. 80(8). 842–842. 77 indexed citations
3.
Jauhar, Sameer, Robert A. McCutcheon, Mattia Veronese, et al.. (2023). The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment. Translational Psychiatry. 13(1). 184–184. 5 indexed citations
4.
Bhui, Kamaldeep, Asit B. Biswas, Samuel R. Chamberlain, et al.. (2022). Impact of COVID-19 on mental health research: is this the breaking point?. The British Journal of Psychiatry. 220(5). 254–256. 5 indexed citations
5.
Navacerrada, Maria Elisa Serrano, Eugene Kim, Karen Randall, et al.. (2022). Erbb4Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes. Schizophrenia Bulletin. 49(3). 569–580. 6 indexed citations
6.
7.
Modinos, Gemma, Anja Richter, Alice Egerton, et al.. (2021). Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes. Neuropsychopharmacology. 46(8). 1468–1474. 22 indexed citations
8.
Nikolova, Viktoriya L., Anthony J. Cleare, Allan H. Young, & James Stone. (2021). Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment. Journal of Clinical Medicine. 10(4). 647–647. 66 indexed citations
9.
Gomes, Felipe V., Diana Cash, Daniela L. Uliana, et al.. (2021). GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology. 47(3). 687–695. 9 indexed citations
10.
Bloomfield, Michael, Kat Petrilli, Rachel Lees, et al.. (2021). The Effects of Acute Δ9-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 6(6). 660–667. 3 indexed citations
11.
Allen, Paul, Emily Hird, Natasza Orlov, et al.. (2021). Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function. Translational Psychiatry. 11(1). 579–579. 5 indexed citations
12.
Gifford, George, Nicolás Crossley, Sarah E. Morgan, et al.. (2020). Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis. Human Brain Mapping. 42(2). 439–451. 2 indexed citations
13.
Howes, Oliver, Ilaria Bonoldi, Robert A. McCutcheon, et al.. (2019). Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study. Neuropsychopharmacology. 45(4). 641–648. 23 indexed citations
14.
Nikolova, Viktoriya L., et al.. (2019). Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis. SHILAP Revista de lepidopterología. 9. 3627425531–3627425531. 43 indexed citations
15.
McQueen, Grant, John Lally, Anthony S. Gabay, et al.. (2019). Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia. Psychopharmacology. 237(2). 443–451. 11 indexed citations
16.
Modinos, Gemma, Fatma Şimşek, Matilda Azis, et al.. (2018). Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis. Neuropsychopharmacology. 43(13). 2652–2659. 39 indexed citations
17.
Winton‐Brown, Toby, et al.. (2015). Sensorimotor gating, cannabis use and the risk of psychosis. Schizophrenia Research. 164(1-3). 21–27. 12 indexed citations
18.
Englund, Amir, Paul D. Morrison, Judith Nottage, et al.. (2012). Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology. 27(1). 19–27. 361 indexed citations breakdown →
19.
Mechelli, Andrea, Anita Riecher‐Rössler, Eva Meisenzahl, et al.. (2011). Neuroanatomical Abnormalities That Predate the Onset of Psychosis. Archives of General Psychiatry. 68(5). 489–489. 197 indexed citations
20.
Dunn, Joel, James Stone, Marcel Cleij, et al.. (2010). DIFFERENTIAL OCCUPANCY OF STRIATAL VERSUS EXTRASTRIATAL DOPAMINE D2/D3 RECEPTORS BY THE TYPICAL ANTIPSYCHOTIC HALOPERIDOL IN MAN MEASURED USING I [18F]-FALLYPRIDE PET. Journal of Psychopharmacology. 24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Pittman Breakdown of academic impact, for papers by Jeffrey H. Meyer Breakdown of academic impact, for papers by Jarmo Hietala Breakdown of academic impact, for papers by David Copolov Breakdown of academic impact, for papers by William M. McDonald Breakdown of academic impact, for papers by Nakao Iwata Breakdown of academic impact, for papers by Gregor Hasler Breakdown of academic impact, for papers by Shigenobu Kanba Breakdown of academic impact, for papers by William G. Honer Breakdown of academic impact, for papers by John Rotrosen
Rankless by CCL
2026